Atrial Fibrillation Market 2023 - Market Size, Share, Growth Analysis, Business Insights And Forecast To 2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Atrial Fibrillation Global Market Report 2023 identifies increase in the geriatric population as the major driver for the atrial fibrillation market's growth in the forecast period. The geriatric population refers to adults 65 and older who are more likely to fall due to various factors, such as postural hypotension and balance or gait problems. Age factor and conduction disturbances are present on the surface electrocardiogram before AF onset in most geriatric patients.

The global atrial fibrillation market size is expected to grow from $10.76 billion in 2022 to $12.07 billion in 2023, at a compound annual growth rate (CAGR) of 12.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The atrial fibrillation market size is expected to grow to $18.90 billion in 2027 at a CAGR of 11.9%.

Download Free Sample Of Atrial Fibrillation Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

Major competitors in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. KG, Boston Scientific Corporation.

A key trend in the atrial fibrillation market includes technological developments. Major companies operating in the healthcare industry are developing new technologies to maintain their position in the atrial fibrillation market. For instance, in October 2020, Biosense Webster, a US-based healthcare company specialized in the diagnosis and treatment of cardiac rhythm abnormalities, received FDA approval for a new technology called The Thermocool Smarttouch Catheter for use in AFib patients. The newly approved technology has been found beneficial for persistent atrial fibrillation, which is defined as AFib occurring for longer than a week but less than a year.

Read More On The Global Atrial Fibrillation Market Report Here:
https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

The atrial fibrillation market is segmented -
1) By Type: Surgical, Non-Surgical

2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies

3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion

4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the atrial fibrillation market.

The Business Research Company's "Global Atrial Fibrillation Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Atrial Fibrillation Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8007

The Table Of Content For The Atrial Fibrillation Market Include:
1. Executive Summary
2. Atrial Fibrillation Market Characteristics
3. Atrial Fibrillation Market Trends And Strategies
4. Atrial Fibrillation Market - Macro Economic Scenario
5. Atrial Fibrillation Market Size And Growth
……
26. Africa Atrial Fibrillation Market
27. Atrial Fibrillation Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Atrial Fibrillation Market
29. Atrial Fibrillation Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.